Andong Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Type 2 diabetes1 trial

Phase

• Phase 41 trial

Status

• Recruiting2 trials

Lead sponsor

• Boryung Pharmaceutical Co., Ltd1 trial
• Seoul National University Hospital1 trial

Running trials

• Recruiting

  A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy

  NCT06649162· Boryung Pharmaceutical Co., Ltd· Source

  Contact: Joong-kyung Sung

• Recruiting

  Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)

  NCT05845489· Phase 4· Seoul National University Hospital· Source

  Contact: Joong Kyung Sung, MD,PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Type 2 diabetes1 recruiting